Viking Therapeutics, Inc. offers promising advances in obesity and liver diseases, despite a recent stock drop over GLP-1 market concerns. Click for my VKTX update.

India equity was one of the top-performing markets in the APAC region, with its equity market advancing 13.3% in 2024, driven by solid domestic fundamentals and rising capex growth.